Treatment of Celiac Artery Compression Syndrome in Asymptomatic Median Arcuate Ligament Syndrome
Clinical Scenario
This protocol applies to celiac artery compression syndrome occurring in the setting of asymptomatic median arcuate ligament syndrome — where celiac artery stenosis is present but the patient has no overt symptoms. The asymptomatic status is a defining factor that shapes the treatment strategy.
Management Approach
An endovascular approach — percutaneous transluminal angioplasty (PTA) and stenting without median arcuate ligament release — is applicable in this asymptomatic presentation. The specific stent selection, sizing, and procedural sequence are detailed in the full structured protocol.
Treatment Goals
The primary objectives are improvement in visceral artery hemodynamics and sustained stent patency, assessed at follow-up.
References
DOI: 10.3390/jvd4010011
- The use of only PTA and stenting without MAL release is possible in asymptomatic patients.
- It is possible to implant only an uncovered balloon-expandable stent such as Express Vascular SD (Boston Scientific, Marlborough, MA, USA) with a diameter of 6.0–14 mms.
- At 15-month follow-up, improvements in visceral artery hemodynamics and stent patency were observed, confirming the high efficacy of this method.